Femme et Homme
- | Pays :
- Denmark
- | Organes : -
- | Spécialités : -
Extrait
It is the primary objective of this study to show safety and tolerability for administration of the cell based immunotherapy ALECSAT to patients with Glioblastoma brain cancer. It is a secondary objective to establish if any indications of positive therapeutic or palliative effects may be observed.
Critère d'inclusion
- Glioblastoma Multiforme